DocGo Company Leadership
| DCGO Stock | USD 1.45 0.01 0.68% |
About 66 percent of all DocGo's insiders are acquiring. The analysis of insiders' sentiment of trading DocGo Inc stock suggests that quite a few insiders are confidant at this time. DocGo employs about 3.4 K people. The company is managed by 17 executives with a total tenure of roughly 7943 years, averaging almost 467.0 years of service per executive, having 200.24 employees per reported executive.
Insider Sentiment 66
Mostly Buying
Selling | Buying |
Latest Trades
| 2025-05-15 | Michael J Burdiek | Acquired 15000 @ 1.43 | View | ||
| 2025-05-14 | Stephen Sugrue | Acquired 10000 @ 1.44 | View | ||
| 2024-12-16 | Ely D Tendler | Disposed 23088 @ 4.44 | View |
Monitoring DocGo's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. DocGo Management Team Effectiveness
As of the 27th of July 2025, Return On Tangible Assets is likely to grow to 0.05. Also, Return On Capital Employed is likely to grow to 0.09. At this time, DocGo's Return On Tangible Assets are very stable compared to the past year. As of the 27th of July 2025, Return On Assets is likely to grow to 0.05, while Total Assets are likely to drop about 339.2 M. DocGo's management efficiency ratios could be used to measure how well DocGo manages its routine affairs as well as how well it operates its assets and liabilities.As of the 27th of July 2025, Common Stock Shares Outstanding is likely to grow to about 112.4 M. Also, Net Income Applicable To Common Shares is likely to grow to about 41.8 M
DocGo Workforce Comparison
DocGo Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 199,878. DocGo claims roughly 3,404 in number of employees contributing just under 2% to equities under Health Care industry.
DocGo Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DocGo insiders, such as employees or executives, is commonly permitted as long as it does not rely on DocGo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DocGo insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ely Tendler few days ago Disposition of 10000 shares by Ely Tendler of DocGo at 1.59 subject to Rule 16b-3 | ||
Lee Bienstock over three weeks ago Disposition of 18597 shares by Lee Bienstock of DocGo at 1.52 subject to Rule 16b-3 | ||
Lee Bienstock over two months ago Acquisition by Lee Bienstock of 15000 shares of DocGo at 1.54 subject to Rule 16b-3 | ||
Stanley Vashovsky over three months ago Disposition of 1500000 shares by Stanley Vashovsky of DocGo subject to Rule 16b-3 | ||
Lee Bienstock over three months ago Disposition of 59360 shares by Lee Bienstock of DocGo at 3.03 subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Disposition of 18598 shares by Lee Bienstock of DocGo at 4.23 subject to Rule 16b-3 | ||
Leite Etalvina over six months ago Disposition of 16500 shares by Leite Etalvina of DocGo at 4.34 subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Acquisition by Lee Bienstock of 536993 shares of DocGo subject to Rule 16b-3 |
DocGo Notable Stakeholders
A DocGo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DocGo often face trade-offs trying to please all of them. DocGo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DocGo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James MD | CEO Board | Profile | |
| Stanley Vashovsky | CoFounder Chairman | Profile | |
| Norman Rosenberg | Treasurer CFO | Profile | |
| Ben Sherman | EVP Development | Profile | |
| Anthony Capone | President | Profile | |
| Ely Tendler | Secretary Counsel | Profile | |
| Aaron Severs | Chief Officer | Profile | |
| Mike Cole | Vice Relations | Profile | |
| Lee Bienstock | Chief Officer | Profile | |
| Andre CPA | Executive Strategy | Profile | |
| Mark Merlin | LLC Holdings | Profile | |
| Ely JD | Secretary Counsel | Profile | |
| Stephen Sugrue | Chief Officer | Profile | |
| Vrenely Munoz | Chief Officer | Profile | |
| Eiwe Lingefors | Chief Officer | Profile | |
| Stan Vashovsky | Chairman CoFounder | Profile | |
| Rosemarie Milano | Vice Resources | Profile |
About DocGo Management Performance
The success or failure of an entity such as DocGo Inc often depends on how effective the management is. DocGo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DocGo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DocGo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.05 | |
| Return On Capital Employed | 0.09 | 0.09 | |
| Return On Assets | 0.04 | 0.05 | |
| Return On Equity | 0.06 | 0.07 |
DocGo Workforce Analysis
Traditionally, organizations such as DocGo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DocGo within its industry.DocGo Manpower Efficiency
Return on DocGo Manpower
| Revenue Per Employee | 181.1K | |
| Revenue Per Executive | 36.3M | |
| Net Income Per Employee | 3.9K | |
| Net Income Per Executive | 785.9K | |
| Working Capital Per Employee | 53.7K | |
| Working Capital Per Executive | 10.7M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.09 | Earnings Share (0.01) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets |
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.